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m963103 ClinicalValidityof NormalCompressionUltrasoundfor SuspectedDeep-VeinThrombosis
inOutpatients
B.G. Birdwell, G.E. Raskob, T.L. Whitsett, S.S. Durica. The LAriversityof
O/dahonraHealth Sciences Cerrteri Oklahoma City O/r/ahorna,USA
Compression ultrasound (C-US) is highly sensitive and specific for proximal
deep-vein thrombosis (DVT) in symptomatic outpatients. However, only lim-
ited data are available on the clinical outcome of patients managed based
on C-US. We perlormed a prospective cohorl study to evaluate the safety
of withholding anticoagulant therapy in outpatients with clinically suspected
first-episode DVT who have normal C-US results. C-US was performed on
presentation, and if normal, repeated ones 5-7 days later. C-US was per-
formed using a simplified exam limited to the common femoral vein and
the popliteal vein extending distally to the trifurcation. Anticoagulants were
withheld in ail patients normal by C-US. The validity of this approach was
tested by follow-up for 3 months. Of 405 consecutive Qatients,70 (17%) were
abnormal by C-US and 335 pstienta remained normal. Of 70 patients with
abnormal results, 63 (90%) were detected at presentation and 7 on repeat
testing. Follow-up for 3 months was completed in all 405 patients. None
were lost to follow-up. None of the 335 patients normal by C-US died from
pulmonary embolism (957. Cl, O to 1.1%). Two had symptomatic venous
thromboembolism confirmed by objective testing (0.6Y0,95% Cl 0.077. to
2.2%). It is safe to withhold anticoagulant therapy in outpatients with sus-
paeted first-episode DVT who are normal by C-US testing.
m963104 PowerDopplerUltrasoundin Detsctionof DespVenousThrombosis
M. Nishino, J. Tanouchi, T. No,Y.Wada, J. Kate, Y. Doi, K. Iwai,
H. Tanahashi, Y.Yamada, T. Kamada. Osaka Rosai f-foapital,Osaka, Japan
Deep venous thrombosis (DVT) sometimes induce life-threatening compli-
cations. Compression ultrasound has been shown a high accuracy in the
diagnosis of DVT, however it is sometimes difficult to compress the vein in
the very obese patients even if they had no DVT.Thus, color Doppler (CD)
ultrasound wee applied to detect DVT, but some repcm have demonstrated
low accuracy of CD. In this study power Doppler (PD) ultrasound, which
recently developed to detect very low velocity flow independent of Doppler
incident angle, was applied to the detection of DVT. Consecutive 70 outpa-
tients with signs of swelling of lower extremity, who were 10 with pulmonary
embolism (PE), 7 with antiphospholipid-antibocfy syndrome (APS) and 53
with idiopathic edema, underwent compression, CD, and PD ultrasound. The
criteria for DVT by each ultrasound method are noncompressibility,absence
ofeolor in vein lumen, and flow defect in vein lumen, respectively.Soon after
ultrasound examinations, venogrephy was performed to diagnose DVT and
the reaults were Comparedwith each ultrasound examination independently.
As a result, venogrsphy reveafed seven DVT patients (10%), in whom 4 had
PE (4410:40%) and 3 had APS (&7: 66%). The sensitivity and specificity of
deteefion of DVT be each ultrasound method was as follows:
Ultrasound Compression CD PD
Sensitivity loim 86% 10D”A
Specificity 97Y. 95% 100%
Compared with compression ultrseound, CD and PD ultrasound are eu-
perior from the point of view of lees demanding and less time-consuming.
However, in CD, the image quality depends on Doppler incident angle and
the image near the vein wall usually poor. These results indicate that power
Doppler ultrasound is an accurate and useful method for detecting DVT
and this method should be performed especiaffy in the outpatients with
edema complicated with pulmonary embolism or antiphospholipid-antibody
syndrome.
1963-1051 ASimpleBSdsideClinical-EchocardiograPhic
AlgorithmisVerySpecificofseverePulmonary
Embolism:A ProspectiveStudyin43Cases
P. Michon, Ph. Asseman, L. Chartier, C. Loubeyre, J.J. Bauchart,
M. Lesenne, Cl. Thery. f-f@ita/ Cardio/ogique, Line, France
A repid bedside noninvasive diagnostic strategy for severe pulmonaty em-
bolism (PE) is still needed. We prospective/y studied the diagnostic value of
a clinical – no preexisting cardiopulmonary disease - and echocardiographic
- a dilated right ventricle (RV) and/or pulmonaty hypertension without left
ventricular (LV) or mitral disease – algorithm. It was tested in 43 patients,
with 27 confirmed PE (pulmona~ angiography and/or isotopic scanning).
Results: 1) In the patients with confirmed PE (n = 27), a) there was a
RV dilatation in 84 percent, b) paradoxical septal motion in 75 percent, c)
thrombus of the right cardiac cavities (RCC) in 18.5 of casee, d) systolic
pulmonary artery pressure was 55 + 12 mmHg. 2) In the patients with RV
dilatation (n = 23), a) diagnosis of PE was made in 91.3 percent (one pre-
viously undetected primary pulmonary hypertension was the rare differential
diagnosis), b) a thrombus of RCC was seen in 21.7 percent of cases. 3) In
the patients without PE (n = 16), a) there was no RV dilatation in 87 percent,
b) septal motion was normal in 85.7 percent, c) there was no thrombus in
RCC in 1~ percent of cases. 4) In the patients with normal RV (n = 17), a)
PE was not diagnosed in 78.5 percent, b) there was no thrombus in the RCC
in 100 percent of cases, 5) Only 3 patients were anechogene (6.9 percent).
Conclusion: 1) A simple bedside clinical-echocardiographic algorithm is
highly specific (87 percent) in identifying severe PE with a positive predictive
value,of 91.3 percent. 2) Conversely, negative predictive value is low (76.5
percent), but patients without echocerdiographic evidence of RV overtoad or
pulmonary hypertension have mild PE, that require further diagnostic etudies,
tailored to their low risk.
m963106 UrokinaseImprovesEndothelium-DependentRelaxationin ExperimentalPulmonaryEmboiiam
W.L. Daley, G.V.R.K. Sharma. West Roxbury WA.Medical Cente~ Brigham,
MA, USA, Women’s Hospital, Harvard Medical School, Boston, MA, USA
We recently obsewed that endothelium-dependent vasodilatation is atten-
uated in experimental pulmona~ embcdism (PE). In order to examine the
effect of urokinase (UK), PE was created in 22 mongrel dogs by injaeting
autologous thrombin-clots into the jugular vein. Selected cine angiograms of
a segmental pulmonary artery (PA) were obtained after infusion of graded
concentrations of acetylcholine (ACh) (10-9 to 1O-g M) followed by an infu-
sion of 40 Kg of nitroglycerin (TNG) into the PA before and after PE and after
an infusion of UK (4400 units/kg in 10 minutes followed by the same dose in
one hour). Percent change in PA diameter was measured ueing quantitative
angiography. Dose response curves obtained from mean values for control,
PE and UK for each infusion of ACh and TNG are displayed.
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Infusion of ACh after PE attenuated the PA response (p <0.05 control
vs PE), with minimal change in PA diameter. Infusion of UK improved the
attenuated PA response to ACh (p <0.05 UK vs PE). Infusion of TNG, both
before and after UK, produced pulmonary vasodilatation indicating preserved
endothelium-independent relaxation. Conclusion: UK improves the impaired
endothelium-dependent pulmonary vasodilatation in experimental PE.
m963107 RelationBetweenTimeto Achievethe LowerLimitof APTTRangeandRecurrentVenous
Thromboembolismin PatientsWithVenous
Thrombosis
G.E.,Raskob, R.D. Hull, G.F. Pineo, K.A. Valentine, R.F. Bran!. Univereityof
Calgary Calgary Alberta, Canada, University of Oklahoma, Oklahoma City
Oklahoma, USA
Monitoring heparin using the APTTto establish therapeutic doses in patients
with deep-vein thrombosis remains a standard of care. A randomized double
blind trial compared subcutaneous (SC)and intravenous (iv) heparin for initial
treatment. Before the trial, we hypothesized that exceeding the lower limit of
the APTT range was important to clinical outcome. The sc regimen resulted
in an APTT response below the predefine lower Iimitfor 24 hours or more in
38/57 patients (63%) and a high rate of recurrent venous thromboembolism
(VTE, 11/57, 19%); iv heparin resulted in an initial APTTbelow the lower limit
in 17/58 patients (29%) (p < 0.001) and reduced recurrent VTE (3/58, 5%)
(p= 0.024).
